CARM1-expressing Ovarian Cancer Depends on the Histone Methyltransferase EZH2 Activity

Nature Communications - United Kingdom
doi 10.1038/s41467-018-03031-3
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Genomic Loss of microRNA-101 Leads to Overexpression of Histone Methyltransferase EZH2 in Cancer

Science
MultidisciplinaryPhilosophy of ScienceHistory
2008English

Insights Into Histone Code Syntax From Structural and Biochemical Studies of CARM1 Methyltransferase

EMBO Journal
ImmunologyMolecular BiologyBiochemistryMicrobiology NeuroscienceMedicineGenetics
2007English

S-Adenosyl-L-Methionine-Competitive Inhibitors of the Histone Methyltransferase EZH2 Induce Autophagy and Enhance Drug Sensitivity in Cancer Cells

Anti-Cancer Drugs
Cancer ResearchOncologyPharmacology
2015English

Steroidogenic Differentiation and PKA Signaling Are Programmed by Histone Methyltransferase EZH2 in the Adrenal Cortex

Yearbook of Paediatric Endocrinology
2019English

Oncogenic Roles of the SETDB2 Histone Methyltransferase in Gastric Cancer

Oncotarget
Oncology
2016English

PRDM16 Suppresses MLL1r Leukemia via Intrinsic Histone Methyltransferase Activity

Molecular Cell
Cell BiologyMolecular Biology
2016English

Activity of PXD101, a Histone Deacetylase Inhibitor, in Preclinical Ovarian Cancer Studies

Molecular Cancer Therapeutics
Cancer ResearchOncology
2006English

The Deletion of the Protein Phosphatase-1 Regulator NIPP1 in Testis Causes Hyperphosphorylation and Degradation of the Histone Methyltransferase EZH2

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2018English

Two Loops Undergoing Concerted Dynamics Regulate the Activity of the ASH1L Histone Methyltransferase

Biochemistry
Biochemistry
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy